This 90-minute web training will provide an overview of the various formulations of buprenorphine (including tablet, film, implantable, and injectable) for the treatment of opioid use disorder. Larissa Mooney, MD, and David Grelotti, MD, will discuss the differences in the delivery of each formulation as well as provide their clinical practice experiences with each formulation. A consumer will discuss finding the right formulation for his treatment.
The Pacific Southwest ATTC & the California Hub and Spoke System Present: Understanding Buprenorphine Formulations and Clinical Guidelines for Use
Collaborating TTC: Pacific Southwest ATTC
April 15, 2020